Conserved structure and function in the granulysin and NK-lysin peptide family

Infection and Immunity

Volumn 73, Issue 10, 2005, Pages 6332-6339

  Linde, Charlotte M A ^a   Grundström, Susanna ^b   Nordling, Erik ^c   Refai, Essam ^c   Brennan, Patrick J ^d   Andersson, Mats ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; GRANULYSIN; LYSINE; NK LYSIN; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CHICKEN; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MYCOBACTERIUM SMEGMATIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ARGININE; CELLS, CULTURED; CONSERVED SEQUENCE; ESCHERICHIA COLI; HUMANS; LYSINE; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SMEGMATIS; PEPTIDES; PROTEIN CONFORMATION; PROTEOLIPIDS;

EID: 25444434865     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.10.6332-6339.2005     Document Type: Article

References (37)

1. Abagyan, R., S. Batalov, T. Cardozo, M. Totrov, J. Webber, and Y. Zhou. 1997. Homology modeling with internal coordinate mechanics: deformation zone mapping and improvements of models via conformational search. Proteins 1(Suppl.):29-37.
2. Anderson, D. H., M. R. Sawaya, D. Cascio, W. Ernst, R. Modlin, A. Krensky, and D. Eisenberg. 2003. Granulysin crystal structure and a structure-derived lytic mechanism. J. Mol. Biol. 325:355-365.
3. Andersson, M., T. Curstedt, H. Jornvall, and J. Johansson. 1995. An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett. 362:328-332.
4. Andersson, M., H. Gunne, B. Agerberth, A. Boman, T. Bergman, R Sillard, H. Jornvall, V. Mutt, B. Olsson, H. Wigzell, et al. 1995. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. EMBO J. 14:1615-1625.
5. Andersson, M., A. Holmgren, and G. Spyrou. 1996. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity. J. Biol. Chem. 271:10116-10120.
6. Andra, J., and M. Leippe. 1999. Candidacidal activity of shortened synthetic analogs of amoebapores and NK-lysin. Med. Microbiol. Immunol. (Berlin) 188:117-124.
7. Andreu, D., C. Carreno, C. Linde, H. G. Boman, and M. Andersson. 1999. Identification of an anti-mycobacterial domain in NK-lysin and granulysin. Biochem. J. 344:845-849.
8. Bjorkhem-Bergman, L., K. Jonsson-Videsater, C. Paul, M. Bjornstedt, and M. Andersson. 2004. Mammalian thioredoxin reductase alters cytolytic activity of an antibacterial peptide. Peptides 25:1849-1855.
9. Boman, H. G., D. Wade, I. A. Roman, B. Wahlin, and R. B. Merrifield. 1989. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett. 259:103-106.
10. Bonetto, V., M. Andersson, T. Bergman, R. Sillard, Å. Norberg, V. Mutt, and H. Jörnvall. 1999. Spleen antibacterial peptides: high levels of PR-39 and presence of two forms of NK-lysin. Cell Mol. Life Sci. 56:174-178.
11. Brosch, R., A. S. Pym, S. V. Gordon, and S. T. Cole. 2001. The evolution of mycobacterial pathogenicity: clues from comparative genomics. Trends Microbiol. 9:452-458.
12. Davis, E. G., Y. Sang, B. Rush, G. Zhang, and F. Blecha. 2005. Molecular cloning and characterization of equine NK-lysin. Vet. Immunol. Immunopathol. 105:163-169.
13. Dieli, F., M. Troye-Blomberg, J. Ivanyi, J. J. Fournie, A. M. Krensky, M. Bonneville, M. A. Peyrat, N. Caccamo, G. Sireci, and A. Salerno. 2001. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J. Infect. Dis. 184:1082-1085.
14. Endsley, J. J., J. L. Furrer, M. A. Endsley, M. A. McIntosh, A. C. Maue, W. R. Waters, D. R. Lee, and D. M. Estes. 2004. Characterization of bovine homologues of granulysin and NK-lysin. J. Immunol. 173:2607-2614.
15. Ericson, K. G., B. Fadeel, M. Andersson, G. H. Gudmundsson, A. Gurgey, N. Yalman, G. Janka, M. Nordenskjold, and J. I. Henter. 2003. Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosis. Hum. Genet. 112:98-99.
16. Ernst, W. A., S. Thoma-Uszynski, R. Teitelbaum, C. Ko, D. A. Hanson, C. Clayberger, A. M. Krensky, M. Leippe, B. R. Bloom, T. Ganz, and R. L. Modlin. 2000. Granulysin, a T cell product, kills bacteria by altering membrane permeability. J. Immunol. 165:7102-7108.
17. Greenfield, N., and G. D. Fasman. 1969. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8:4108-4116.
18. Hultmark, D., Å. Engström, K. Andersson, H. Steiner, H. Bennich, and H. G. Boman. 1983. Insect immunity. Attacins, a family of antibacterial proteins from Hyalophora cecropia. EMBO J. 2:571-576.
19. Jongstra, J., T. J. Schall, B. J. Dyer, C. Clayberger, J. Jorgensen, M. M. Davis, and A. M. Krensky. 1987. The isolation and sequence of a novel gene from a human functional T cell line. J. Exp. Med. 165:601-614.
20. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132.
21. Lee, J. Y., A. Boman, C. X. Sun, M. Andersson, H. Jornvall, V. Mutt, and H. G. Boman. 1989. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc. Natl. Acad. Sci. USA 86:9159-9162.
22. Liepinsh, E., M. Andersson, J. M. Ruysschaert, and G. Otting. 1997. Saposin fold revealed by the NMR structure of NK-lysin. Nat. Struct. Biol. 4:793-795. (Letter.)
23. Linde, C. M., S. E. Hoffner, E. Refai, and M. Andersson. 2001. In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother. 47:575-580.
24. Miteva, M., M. Andersson, A. Karshikoff, and G. Otting. 1999. Molecular electroporation: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK-lysin. FEBS Lett. 462:155-158.
25. Miyakawa, Y., P. Ratnakar, A. Gururaj Rao, M. L. Costello, O. Mathieu-Costello, R. I. Lehrer, and A. Catanzaro. 1996. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect. Immun. 64:926-932.
26. Morrisett, J. D., J. S. David, H. J. Pownall, and A. M. J. Gotto. 1973. Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry 12:1290-1299.
27. Pena, S. V., D. A. Hanson, B. A. Carr, T. J. Goralski, and A. M. Krensky. 1997. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 158:2680-2688.
28. Peschel, A., M. Otto, R. W. Jack, H. Kallbacher, G. Jung, and F. Götz. 1999. Inactivation of the dtl operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274:8405-8410.
29. Raj, A. R., and A. R. Dentino. 2002. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol. Lett. 206:9-18.
30. Resnitzky, P., A. Bustan, A. Peled, and Y. Marikovsky. 1988. Variations in surface charge distributions of leukemic and non-leukemic transformed cells. Leukoc. Res. 12:315-320.
31. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
32. Stamm, L. M., and E. J. Brown. 2004. Mycobacterium marinum: the generalization and specialization of a pathogenic mycobacterium. Microbes Infect. 6:1418-1428.
33. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, S. A. Porcelli, B. R. Bloom, A. M. Krensky, and R. L. Modlin. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121-125.
34. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
35. Tirunagaru, V. G., L. Sofer, J. Cui, and J. Burnside. 2000. An expressed sequence tag database of T-cell-enriched activated chicken splenocytes: sequence analysis of 5251 clones. Genomics 66:144-151.
36. Wang, Z., E. Choice, A. Kaspar, D. Hanson, S. Okada, S. C. Lyu, A. M. Krensky, and C. Clayberger. 2000. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J. Immunol. 165:1485-1490.
37. Yabe, T., C. McSherry, F. H. Bach, and J. P. Houchins, 1990. A cDNA clone expressed in natural killer and T cells that likely encodes a secreted protein. J. Exp. Med. 172:1159-1163.